600867.SH
通化东宝
SSE · Healthcare · Drug Manufacturers - General · CN
CNY 7.95
−1.97%Price chart
Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4
ValuationView details →
P/E (Fwd)
29.7x
EV/EBITDA
7.7x
Market Cap
CNY 15.57B
MomentumView details →
1D Return
−1.97%
YTD Return
−1.84%
RSI (14)
43.8
ValuationView details →
P/E (Fwd)
29.7x
EV/EBITDA
7.7x
Market Cap
CNY 15.57B
RSI (14)
43.8
MomentumView details →
1D Return
−1.97%
YTD Return
−1.84%
Similar companies
Latest newsMore news →
Tonghua Dongbao announced its first-half 2026 results: net profit attributable to shareholders was 296 million yuan, up 37.32% year-on-year, with revenue of 1.553 billion yuan, up 11.13%.11d agoTonghua Dongbao subscribed to 1.62 million convertible bonds issued by Tebao Bio for 162 million yuan, which were fully allocated and will be listed on the Shanghai Stock Exchange on August 13, 2026.24d ago